These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 20547124)

  • 1. Genetic animal models of Parkinson's disease.
    Dawson TM; Ko HS; Dawson VL
    Neuron; 2010 Jun; 66(5):646-61. PubMed ID: 20547124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death pathways in Parkinson's disease: role of mitochondria.
    Yao Z; Wood NW
    Antioxid Redox Signal; 2009 Sep; 11(9):2135-49. PubMed ID: 19422283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease--a multifactorial neurodegenerative disorder.
    Riess O; Krüger R
    J Neural Transm Suppl; 1999; 56():113-25. PubMed ID: 10370906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: from genetics to treatments.
    Fan HC; Chen SJ; Harn HJ; Lin SZ
    Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Developments in Genetic rat models of Parkinson's Disease.
    Creed RB; Goldberg MS
    Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for Parkinson's disease.
    Patil DA; Patil VA; Bari SB; Surana SJ; Patil PO
    CNS Neurol Disord Drug Targets; 2014; 13(9):1580-94. PubMed ID: 25106631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: genetic versus toxin-induced rodent models.
    Terzioglu M; Galter D
    FEBS J; 2008 Apr; 275(7):1384-1391. PubMed ID: 18279376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
    Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
    PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1: a newcomer in Parkinson's disease pathology.
    da Costa CA
    Curr Mol Med; 2007 Nov; 7(7):650-7. PubMed ID: 18045143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
    Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A
    Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
    Kim J; Daadi EW; Oh T; Daadi ES; Daadi MM
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into Parkinson's disease.
    Chung KK; Dawson VL; Dawson TM
    J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.